Now available is the most up-to-date research on, “Changing Regulatory and Reimbursement Scenario for Medical Devices in the U.S. Market.” The report focuses primarily on quantitative market metrics in order to characterize the growth and evolution of the reimbursement scenario for U.S. medical devices market.
“Changing Regulatory and Reimbursement Scenario for Medical Devices in the U.S. Market” looks at the regulatory landscape and reimbursement scenario in the U.S. for four medical device markets (http://www.researchmoz.us/changing-regulatory-and-reimbursement-scenario-for-medical-devices-in-the-us-market-report.html): cardiovascular devices, neurostimulation devices, diagnostic imaging devices, and endoscopy devices.
The report provides comprehensive information on establishment registration, medical device listing, Premarket Notification (510k) or Premarket Approval (PMA), Investigational Device Exemption (IDE) for clinical studies, Quality System (QS) regulation, labeling requirements, and Medical Device Reporting (MDR). The report also reviews the reimbursement scenario in these medical device markets. It is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Research’s team of industry experts.
To purchase a copy of this report, click here.